Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
AVAH

AVAH - Aveanna Healthcare Holdings Inc. Stock Price, Fair Value and News

2.25USD-0.03 (-1.32%)Delayed as of 21 Feb 2024, 01:05 pm ET
Watchlist

Market Summary

USD2.25-0.03
Delayedas of 21 Feb 2024, 01:05 pm
-1.32%

AVAH Stock Price

View Fullscreen

AVAH RSI Chart

AVAH Valuation

Market Cap

434.9M

Price/Earnings (Trailing)

-1.25

Price/Sales (Trailing)

0.23

EV/EBITDA

-2.1

Price/Free Cashflow

-29.87

AVAH Price/Sales (Trailing)

AVAH Profitability

EBT Margin

-18.56%

Return on Equity

-28%

Return on Assets

-20.94%

Free Cashflow Yield

-3.35%

AVAH Fundamentals

AVAH Revenue

Revenue (TTM)

1.9B

Rev. Growth (Yr)

7.9%

Rev. Growth (Qtr)

1.29%

AVAH Earnings

Earnings (TTM)

-346.6M

Earnings Growth (Yr)

-521.39%

Earnings Growth (Qtr)

-499.97%

Breaking Down AVAH Revenue

52 Week Range

0.952.28
(Low)(High)

Last 7 days

-5.5%

Last 30 days

-0.4%

Last 90 days

8.1%

Trailing 12 Months

97.5%

How does AVAH drawdown profile look like?

AVAH Financial Health

Current Ratio

0.87

AVAH Investor Care

Shares Dilution (1Y)

2.59%

Diluted EPS (TTM)

-1.86

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20231.8B1.8B1.9B0
20221.7B1.7B1.8B1.8B
20211.6B1.6B1.7B1.7B
20201.4B1.4B1.5B1.5B
20190001.4B

Tracking the Latest Insider Buys and Sells of Aveanna Healthcare Holdings Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Aug 15, 2023
schwartz erica
acquired
-
-
61,611
-
Aug 15, 2023
retchin sheldon m
acquired
-
-
61,611
-
Aug 15, 2023
zoretic richard c
acquired
-
-
61,611
-
Aug 15, 2023
rodgers steven e
acquired
-
-
61,611
-
Aug 15, 2023
ganzi victor f
acquired
-
-
61,611
-
Jun 06, 2023
ganzi victor f
bought
246
1.23
200
-
Jun 01, 2023
ganzi victor f
bought
3,776
1.18
3,200
-
May 31, 2023
ganzi victor f
bought
13,615
1.149
11,850
-
May 30, 2023
ganzi victor f
bought
2,007
1.142
1,758
-
Feb 14, 2023
reisz edwin c.
acquired
-
-
187,500
chief administrative officer

1–10 of 50

Which funds bought or sold AVAH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
reduced
-14.03
96,000
198,000
-%
Feb 16, 2024
GSA CAPITAL PARTNERS LLP
sold off
-100
-167,000
-
-%
Feb 15, 2024
Legal & General Group Plc
added
10.36
7,351
12,254
-%
Feb 15, 2024
BARCLAYS PLC
added
104
251,000
321,000
-%
Feb 15, 2024
JANE STREET GROUP, LLC
added
218
167,860
195,037
-%
Feb 14, 2024
KING STREET CAPITAL MANAGEMENT, L.P.
added
50.59
12,094,500
17,152,000
24.19%
Feb 14, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP
new
-
84,664
84,664
-%
Feb 14, 2024
MILLENNIUM MANAGEMENT LLC
added
417
161,122
176,258
-%
Feb 14, 2024
EAM Investors, LLC
new
-
625,000
625,000
0.11%
Feb 14, 2024
Nuveen Asset Management, LLC
reduced
-4.25
359,038
669,517
-%

1–10 of 50

Are Funds Buying or Selling AVAH?

Are funds buying AVAH calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AVAH
No. of Funds

Unveiling Aveanna Healthcare Holdings Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
nut tree capital management, lp
6.5%
12,372,649
SC 13G
Feb 14, 2022
bcpe eagle investor, lp
44.3%
81,600,880
SC 13G
Feb 14, 2022
j.h. whitney vii, l.p.
8.54%
15,725,196
SC 13G

Recent SEC filings of Aveanna Healthcare Holdings Inc.

View All Filings
Date Filed Form Type Document
Feb 20, 2024
4
Insider Trading
Feb 20, 2024
4
Insider Trading
Feb 20, 2024
4
Insider Trading
Feb 20, 2024
4
Insider Trading
Feb 20, 2024
4
Insider Trading
Feb 14, 2024
SC 13G
Major Ownership Report
Jan 17, 2024
8-K
Current Report
Dec 11, 2023
8-K
Current Report
Nov 14, 2023
8-K
Current Report

Peers (Alternatives to Aveanna Healthcare Holdings Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
481.9B
360.0B
0.01% 5.90%
22.22
1.34
14.24% 11.62%
96.0B
357.8B
0.71% -14.01%
11.5
0.27
10.95% 93.52%
81.6B
65.0B
9.34% 20.24%
15.57
1.26
7.86% -7.11%
42.4B
150.1B
-0.09% 8.25%
17.33
0.28
6.04% 21.35%
11.2B
14.0B
2.25% 10.28%
16.54
0.8
6.03% -8.61%
10.8B
12.1B
12.03% 47.11%
15.6
0.89
4.57% 23.40%
MID-CAP
8.8B
2.2B
0.13% 16.69%
36.12
3.97
4.50% -6.69%
7.7B
2.9B
-3.46% 1.96%
-423.79
2.71
13.16% -106.47%
2.2B
4.1B
-19.95% -33.62%
7.83
0.54
-25.26% -41.31%
SMALL-CAP
2.3B
1.3B
4.99% 11.37%
51.27
1.72
27.06% -27.04%
1.5B
1.0B
8.40% -11.51%
25.75
1.44
10.84% 30.19%
1.2B
3.0B
7.30% 124.36%
-9.39
0.39
6.98% 58.07%
43.7M
-
-0.60% -54.62%
-3.02
-
- -27.68%
17.0M
20.7M
- -15.62%
83.79
0.82
6.53% -85.60%

Aveanna Healthcare Holdings Inc. News

Latest updates
InvestorsObserver14 Feb 202404:53 pm

Aveanna Healthcare Holdings Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Revenue1.3%478,010,000471,945,000466,413,000451,147,000443,009,000442,955,000450,534,000414,070,000411,276,000436,112,000417,160,000422,302,000366,003,000351,577,000355,223,000-
  S&GA Expenses-0.3%91,004,00091,255,00091,708,00089,947,00089,542,00088,998,00088,743,00073,919,00076,370,00077,720,00069,372,00066,491,00059,641,00055,120,00059,694,000-
EBITDA Margin-158.7%-0.10-0.04-0.32-0.30-0.25-0.270.00-0.010.060.060.010.030.02---
Interest Expenses4.2%39,599,00037,985,00035,958,00033,975,00028,462,00022,919,00022,364,00015,137,00012,106,00019,262,00022,425,00024,011,00019,065,00018,844,00021,063,000-
Income Taxes175.0%600,000-800,0001,600,000-1,394,000-2,669,000-300,0002,597,0004,080,000-1,100,000179,000309,0002,393,000-500,0002,300,0001,131,000-
Earnings Before Taxes-510.5%-101,758,00024,789,000-30,432,000-239,143,00021,629,000-474,231,00027,931,000-122,112,000990,0001,439,0006,107,000-7,331,000-7,873,000-75,298,00038,768,000-
EBT Margin-52.4%-0.19-0.12-0.40-0.37-0.31-0.33-0.05-0.070.000.00-0.05-0.03-0.05---
Net Income-500.0%-102,389,00025,599,000-31,998,000-237,779,00024,298,000-473,887,00025,334,000-126,192,0002,090,0001,260,0005,798,000-9,732,000-7,402,000-77,553,00037,637,000-
Net Income Margin-54.7%-0.19-0.12-0.40-0.37-0.31-0.33-0.06-0.070.00-0.01-0.06-0.04-0.05---
Free Cashflow315.3%28,700,000-13,333,0004,680,000-43,051,00018,376,000-21,882,000-13,460,000-39,182,00031,581,00015,877,000-35,576,000-4,580,00039,856,000---
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q4
Assets-5.0%1,6551,7411,7311,7121,9731,9092,3762,3341,9561,9601,7981,844
  Current Assets5.6%318301308270312293286279343346293341
    Cash Equivalents72.4%48.0028.0034.0019.0064.0017.0017.0030.0012210767.00137
  Net PPE10.9%22.0020.0021.0023.0025.0027.0029.0031.0032.0032.0032.0033.00
  Goodwill-9.1%1,0551,1601,1601,1601,3681,3671,8371,8361,4201,4191.001,316
Liabilities0.7%1,7581,7461,7651,7161,7431,7071,7081,6961,1991,2101,5241,577
  Current Liabilities2.4%364356376326352361368345220220207260
Shareholder's Equity0.3%1,2381,2341,2311,229228200666636754748272265
  Retained Earnings-8.2%-1,345-1,243-1,268-1,236-998-1,023-549-574-448-450-451-457
  Additional Paid-In Capital0.3%1,2381,2341,2311,2291,2251,2221,2131,2091,2011,197722721
Shares Outstanding0.2%191190189189185185185185166171142142
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Cashflow From Operations372.9%28,700-10,5187,495-40,23621,191-19,881-9,476-33,53835,80919,290-32,911-1,49941,53232,53244,053-
  Share Based Compensation97.9%5,1162,5852,4421,7853,5125,7814,8154,2834,2625,1687121,0994361,422318-
Cashflow From Investing13.2%-1,127-1,299-4,800-3,199-3,636-1,813-16,643-568,323-4,925-105,418-3,165-132,043-51,021-4,153-6,327-
Cashflow From Financing-235.1%-7,2915,39612,521-1,02928,66321,71813,068510,643-15,725125,572-34,164-1,375195,8331,50514,981-

AVAH Income Statement

2023-09-30
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Income Statement [Abstract]    
Revenue$ 478,010$ 443,009$ 1,416,368$ 1,336,498
Cost of revenue, excluding depreciation and amortization330,746308,426969,384912,046
Branch and regional administrative expenses91,00489,542273,967267,283
Corporate expenses27,44633,21584,735105,984
Goodwill impairment105,136 105,136470,207
Depreciation and amortization2,9624,91710,49416,774
Acquisition-related costs428 46669
Other operating (income) expense(3,360)2,122(6,593)1,953
Operating (loss) income(76,352)4,787(21,221)(437,818)
Interest income50164238369
Interest expense(39,599)(28,462)(113,542)(73,745)
Other income14,14345,14027,12486,523
(Loss) income before income taxes(101,758)21,629(107,401)(424,671)
Income tax (expense) benefit(631)2,669(1,387)416
Net (loss) income$ (102,389)$ 24,298$ (108,788)$ (424,255)
Net (loss) income per share:    
Net (loss) income per share, basic$ (0.54)$ 0.13$ (0.57)$ (2.29)
Weighted average shares of common stock outstanding, basic189,139186,113189,632185,327
Net (loss) income per share, diluted$ (0.54)$ 0.13$ (0.57)$ (2.29)
Weighted average shares of common stock outstanding, diluted189,139186,166189,632185,327

AVAH Balance Sheet

2023-09-30
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 48,294$ 19,217
Patient accounts receivable235,668221,237
Receivables under insured programs10,7244,395
Prepaid expenses12,35215,089
Other current assets11,2079,813
Total current assets318,245269,751
Property and equipment, net22,00022,752
Operating lease right of use assets51,78954,601
Goodwill1,054,5521,159,688
Intangible assets, net95,18895,863
Receivables under insured programs23,18622,865
Other long-term assets89,74386,240
Total assets1,654,7031,711,760
Current liabilities:  
Accounts payable and other accrued liabilities36,52744,624
Accrued payroll and employee benefits75,58843,836
Current portion of insurance reserves - insured programs10,7244,395
Current portion of insurance reserves18,93927,531
Securitization obligations155,000140,000
Current portion of long-term obligations9,2009,200
Current portion of operating lease liabilities13,97213,070
Other current liabilities44,35043,841
Total current liabilities364,300326,497
Long-term obligations, less current portion1,277,5821,281,082
Long-term insurance reserves - insured programs23,18622,865
Long-term insurance reserves44,29135,470
Operating lease liabilities, less current portion42,60345,818
Deferred income taxes4,4193,844
Other long-term liabilities1,900359
Total liabilities1,758,2811,715,935
Commitments and contingencies (Note 11)
Deferred restricted stock units2,1352,135
Stockholders' deficit:  
Preferred stock, $0.01 par value as of April 1, 2023 and December 31, 2022 5,000,000 shares authorized; none issued or outstanding
Common stock, $0.01 par value, 1,000,000,000 shares authorized; 190,733,153 and 188,859,165 issued and outstanding, respectively1,9071,888
Additional paid-in capital1,237,8781,228,512
Accumulated deficit(1,345,498)(1,236,710)
Total stockholders' deficit(105,713)(6,310)
Total liabilities, deferred restricted stock units, and stockholders' deficit$ 1,654,703$ 1,711,760
AVAH
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
 CEO
 WEBSITEwww.aveanna.com
 EMPLOYEES33700

Aveanna Healthcare Holdings Inc. Frequently Asked Questions


What is the ticker symbol for Aveanna Healthcare Holdings Inc.? What does AVAH stand for in stocks?

AVAH is the stock ticker symbol of Aveanna Healthcare Holdings Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Aveanna Healthcare Holdings Inc. (AVAH)?

As of Tue Feb 20 2024, market cap of Aveanna Healthcare Holdings Inc. is 434.87 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AVAH stock?

You can check AVAH's fair value in chart for subscribers.

What is the fair value of AVAH stock?

You can check AVAH's fair value in chart for subscribers. The fair value of Aveanna Healthcare Holdings Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Aveanna Healthcare Holdings Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AVAH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Aveanna Healthcare Holdings Inc. a good stock to buy?

The fair value guage provides a quick view whether AVAH is over valued or under valued. Whether Aveanna Healthcare Holdings Inc. is cheap or expensive depends on the assumptions which impact Aveanna Healthcare Holdings Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AVAH.

What is Aveanna Healthcare Holdings Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Feb 20 2024, AVAH's PE ratio (Price to Earnings) is -1.25 and Price to Sales (PS) ratio is 0.23. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AVAH PE ratio will change depending on the future growth rate expectations of investors.